REGULATED PRESS RELEASE published on 12/09/2024 at 07:01, 1 year 9 months ago BIOFIRE® FILMARRAY® Tropical Fever Panel, un test PCR pour détecter l’origine des fièvres tropicales, obtient l’autorisation spéciale 510(k) de la FDA américaine Le test PCR BIOFIRE® FILMARRAY® Tropical Fever obtient l’autorisation spéciale 510(k) de la FDA pour détecter les fièvres tropicales. Un outil innovant pour un diagnostic précis et rapide BioMérieux Diagnostic Autorisation 510(k) Test PCR Fièvres Tropicales
BRIEF published on 12/05/2024 at 14:02, 1 year 9 months ago BioMérieux : Détails du Capital Social et des Droits de Vote en Novembre 2024 Droits De Vote Capital Social BioMérieux Actions Régulation Financière
BRIEF published on 12/05/2024 at 14:02, 1 year 9 months ago BioMérieux: Details of Share Capital and Voting Rights in November 2024 Share Capital Voting Rights BioMérieux Actions Financial Regulation
REGULATED PRESS RELEASE published on 12/05/2024 at 13:57, 1 year 9 months ago Novembre 2024 - Déclaration sur le nombre d'actions composant le capital social et sur le nombre de droits de vote correspondant Informations mensuelles sur les droits de vote et actions de bioMérieux. Nombre total de droits de vote: 191 136 960 Autorité Des Marchés Financiers Droits De Vote BioMérieux Actions Informations Mensuelles
BRIEF published on 11/06/2024 at 09:59, 1 year 10 months ago État des Actions et Droits de Vote de bioMérieux pour Octobre 2024 Droits De Vote BioMérieux Actions Règlement Financier Octobre 2024
BRIEF published on 11/06/2024 at 09:59, 1 year 10 months ago Status of bioMérieux Shares and Voting Rights for October 2024 Voting Rights BioMérieux Actions Financial Regulation October 2024
REGULATED PRESS RELEASE published on 11/06/2024 at 09:54, 1 year 10 months ago Octobre 2024 - Déclaration sur le nombre d'actions composant le capital social et sur le nombre de droits de vote correspondant bioMérieux informe sur le nombre total de droits de vote et d'actions au 31/10/2024. Les détails sont conformes à la réglementation financière en vigueur Droits De Vote BioMérieux Actions Règlement Général Informations Mensuelles
BRIEF published on 10/30/2024 at 07:06, 1 year 10 months ago BioMérieux Reports Solid Third-Quarter Performance in 2024 Financial Performance Diagnostic Solutions Sales Growth BioMérieux 2024 GO•28 Strategy
BRIEF published on 10/30/2024 at 07:06, 1 year 10 months ago BioMérieux : Croissance organique soutenue au troisième trimestre 2024 BioMérieux Croissance Organique Panels BIOFIRE® SPOTFIRE® GO•28
REGULATED PRESS RELEASE published on 10/30/2024 at 07:01, 1 year 10 months ago bioMérieux – Third-Quarter 2024 Business Review bioMérieux reports strong +10.3% organic sales growth, reaching €2,871m in the first nine months of 2024, driven by growth drivers like GO•28 strategic plan and BIOFIRE® respiratory panels. Q3 2024 shows an +11% organic sales growth with confirmation of 2024 full-year revised guidance. CEO Pierre Boulud expresses confidence in achieving targets BioMérieux Organic Sales Growth 2024 Guidance GO•28 Strategic Plan BIOFIRE Respiratory Panels
Published on 09/23/2026 at 18:25, 18 minutes ago Boba Mint Holdings Ltd. Reports Strong Early Subscription Adoption Following Soft Launch of Amino Pro
Published on 09/23/2026 at 15:42, 3 hours 1 minute ago Global Atomic Announces C$50 Million Public Offering of Units
Published on 09/23/2026 at 14:31, 4 hours 12 minutes ago First Breach Completes First Untethered Flight of Proprietary Drone Prototype, Advancing American-Made Unmanned Systems Program
Published on 09/23/2026 at 14:30, 4 hours 13 minutes ago Phase II Clinical Trial of NV-387 as a Treatment for Monkeypox (MPox) Has Begun in DRC, Announces NanoViricides
Published on 09/23/2026 at 14:00, 4 hours 43 minutes ago Integrated Rewards Launches "Celebrate Canadian" Campaign to Connect Canadian Brands with Millions of Consumers
Published on 09/23/2026 at 18:05, 38 minutes ago XPRIZE Wildfire Awards $4.55M to Innovators Advancing Wildfire Detection and Response
Published on 09/23/2026 at 18:00, 43 minutes ago ARVERNE GROUP: Release of the 2026 half-year financial report
Published on 09/23/2026 at 18:00, 43 minutes ago ARVERNE GROUP: Mise à disposition du rapport financier semestriel 2026
Published on 09/23/2026 at 18:00, 43 minutes ago ARVERNE GROUP: Premier semestre 2026 Croissance de 60,1 % du volume d’activité brut, à 16,8 M€ Des performances opérationnelles supérieures aux attentes
Published on 09/23/2026 at 18:00, 43 minutes ago MHM CORPORATE ANNONCE LE SUCCÈS DE SON AUGMENTATION DE CAPITAL AVEC MAINTIEN DU DROIT PREFERENTIEL DE SOUSCRIPTION AINSI QU’UN REMBOURSEMENT PARTIEL D’OBLIGATIONS REMBOURSABLES EN ACTIONS
Published on 09/23/2026 at 18:00, 43 minutes ago SMTPC - Communiqué sur les résultats du 1er semestre 2026
Published on 09/23/2026 at 17:45, 58 minutes ago Report on share repurchases from 16 to 21 September 2026